TTUHSC School of Medicine
HomeSchool of MedicineContinuing Medical EducationGrand Rounds

Continuing Medical Education

Grand Rounds Detail

Update on the Pathogenesis, Diagnosis, and Treatment of Myelofibrosis in the Era of JAK2 Inhibitors
4/4/2013
Speaker: Alfonso Quintas-Cardama, MD

Department: Internal MedicineRoom: ACB 100
Directly Sponsored: Texas Tech University Health Sciences Center
Time: 12:00 pm to 1:00 pm
Campus: Lubbock

TechLink: Odessa - Room#: 3206


Click to Request More Information

Upon the completion of this activity the participant should be able to:
  • Identify and diagnose patients with myelofibrosis
  • Describe the underlying pathogenesis of myelofibrosis
  • Evaluate current risk stratification tools to treat (or not) patients with myelofibrosis
  • Identify treatment options for patients to recieve up to date medical care for improved quality of life and survival
Accreditation: Texas Tech University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: Texas Tech University Health Sciences Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

©